| | Per 2026 Note | | | Per 2034 Note | | | Total | |
Public offering prices | | | 99.965% | | | 99.637% | | | €1,247,102,500 |
Underwriting discounts | | | 0.225% | | | 0.450% | | | €4,500,000 |
Proceeds, before expenses, to Thermo Fisher | | | 99.740% | | | 99.187% | | | €1,242,602,500 |
BofA Securities (All Notes) | | | Citigroup (All Notes) | | | Deutsche Bank (All Notes) | |||
Goldman Sachs & Co. LLC (All Notes) | | | ING (2026 Notes) | | | Morgan Stanley (2026 Notes) | |||
MUFG (2026 Notes) | | | RBC Capital Markets (2034 Notes) | | | SMBC Nikko (2034 Notes) | | | Scotiabank (2034 Notes) |
Barclays (All Notes) | | | BNP PARIBAS (All Notes) | | | BNY Mellon Capital Markets, LLC (All Notes) | | | Credit Suisse (All Notes) | | | HSBC (All Notes) |
ING (2034 Notes) | | | J.P. Morgan (All Notes) | | | KeyBanc Capital Markets (All Notes) | | | Loop Capital Markets (All Notes) | | | Mizuho (All Notes) |
Morgan Stanley (2034 Notes) | | | MUFG (2034 Notes) | | | NORDEA (All Notes) | | | RBC Capital Markets (2026 Notes) | | | SMBC Nikko (2026 Notes) |
Scotiabank (2026 Notes) | | | US Bancorp (All Notes) | | | Wells Fargo Securities (All Notes) |